Precision Medicine for Localized Prostate Cancer: Time to Move Beyond NCCN Risk Stratification? [electronic resource]
- International journal of radiation oncology, biology, physics 01 2019
- 92-94 p. digital
Publication Type: Editorial; Comment
1879-355X
10.1016/j.ijrobp.2018.09.040 doi
Genomics Humans Male Precision Medicine Prostatic Neoplasms Radiotherapy, Image-Guided